UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CohBar is implementing good security practices.
CohBar, Inc. is a leader in the research and development of mitochondria based therapeutics (MBTs), an emerging class of drugs with the potential to treat a wide range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, Type 2 diabetes (T2D), cancer, cardiovascular disease and CNS disorders.
This report shows a preliminary security rating for CohBar. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
Sensitive data is information that must be protected against unauthorized access. Access to ...
A third-party vendor is any entity that your organization does business with. This includes ...
Compare CohBar's security performance with other companies